Sudarshan Chemical Industries

506655: Future Appointments And Board Actions Will Sustain Upward Momentum

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

06 Feb 25

Updated

01 Nov 25

Views

28

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-13.3%

7D

2.0%

Loading

1Y

-13.3%

7D

2.0%

You can edit this narrative until Nov 2 5:15 AM. Then, changes will post as Updates.

Author's Valuation

₹1.49k33.9% undervalued

AnalystConsensusTarget Fair Value

Shared on 01 Nov 25

Analysts have maintained their fair value estimate for Sudarshan Chemical Industries at ₹1,486, citing stable growth forecasts and consistent key metrics as the basis for their unchanged outlook. What's in the News At the Annual General Meeting held on September 29, 2025, Sudarshan Chemical Industries approved a final dividend of INR 4.50 per equity share for the financial year ended March 31, 2025 (Key Developments).

Shared on 18 Oct 25

Fair value Increased 7.97%

Analysts have raised their price target for Sudarshan Chemical Industries from ₹1,376.29 to ₹1,486.00. This reflects a revised outlook based on updated forecasts and key financial metrics.

Shared on 12 Sep 25

Fair value Increased 14%

The consensus analyst price target for Sudarshan Chemical Industries has increased to ₹1376, reflecting optimism despite a higher forward P/E and a slight decline in net profit margin. What's in the News The board recommended a final dividend of INR 4.50 per equity share for FY 2024-25, subject to shareholder approval.

Shared on 01 May 25

Fair value Increased 4.68%

Shared on 23 Apr 25

Fair value Increased 0.14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Decreased 0.74%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Decreased 0.24%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 13 Mar 25

AnalystConsensusTarget Fair Value

₹1.49k

33.9% undervalued

Future estimation in

Growth p.a.

Growth p.a.

%

Decrease

Increase

Current revenue growth rate

15.37%

Chemicals revenue growth rate

0.61%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

14.28%

Calculation

₹7.42b

Earnings '28

x

34.55x

PE Ratio '28

=

₹256.21b

Market Cap '28

₹256.21b

Market Cap '28

/

115.43m

No. shares '28

=

₹2.22k

Share Price '28

₹2.22k Share Price '28

Discounted to 2025 @ 14.31% p.a.

=

₹1.49k

Fair Value '25